Structure

Physi-Chem Properties

Molecular Weight:  416.26
Volume:  446.056
LogP:  4.62
LogD:  3.681
LogS:  -5.083
# Rotatable Bonds:  8
TPSA:  72.83
# H-Bond Aceptor:  5
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.634
Synthetic Accessibility Score:  3.854
Fsp3:  0.68
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.209
MDCK Permeability:  3.108813689323142e-05
Pgp-inhibitor:  0.903
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.157
30% Bioavailability (F30%):  0.74

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.064
Plasma Protein Binding (PPB):  93.65143585205078%
Volume Distribution (VD):  0.499
Pgp-substrate:  3.70220685005188%

ADMET: Metabolism

CYP1A2-inhibitor:  0.019
CYP1A2-substrate:  0.367
CYP2C19-inhibitor:  0.06
CYP2C19-substrate:  0.912
CYP2C9-inhibitor:  0.134
CYP2C9-substrate:  0.77
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.536
CYP3A4-inhibitor:  0.204
CYP3A4-substrate:  0.417

ADMET: Excretion

Clearance (CL):  3.534
Half-life (T1/2):  0.722

ADMET: Toxicity

hERG Blockers:  0.049
Human Hepatotoxicity (H-HT):  0.272
Drug-inuced Liver Injury (DILI):  0.079
AMES Toxicity:  0.006
Rat Oral Acute Toxicity:  0.045
Maximum Recommended Daily Dose:  0.527
Skin Sensitization:  0.619
Carcinogencity:  0.16
Eye Corrosion:  0.003
Eye Irritation:  0.02
Respiratory Toxicity:  0.139

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC254233

Natural Product ID:  NPC254233
Common Name*:   Abiesadine J
IUPAC Name:   4-[[(1R,4aS,10aR)-7-(2-methoxypropan-2-yl)-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methoxy]-4-oxobutanoic acid
Synonyms:  
Standard InCHIKey:  OSBRSVNOFXCOHR-KSNOWIBYSA-N
Standard InCHI:  InChI=1S/C25H36O5/c1-23(2,29-5)18-8-9-19-17(15-18)7-10-20-24(3,13-6-14-25(19,20)4)16-30-22(28)12-11-21(26)27/h8-9,15,20H,6-7,10-14,16H2,1-5H3,(H,26,27)/t20-,24-,25+/m0/s1
SMILES:  COC(c1ccc2c(c1)CC[C@@H]1[C@]2(C)CCC[C@@]1(C)COC(=O)CCC(=O)O)(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL592464
PubChem CID:   46230077
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO2882 Abies georgei Species Pinaceae Eukaryota aerial parts Zhongdian city, Yunnan Province of China n.a. PMID[20022253]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 > 100.0 ug.mL-1 PMID[572709]
NPT114 Cell Line LoVo Homo sapiens IC50 > 25.0 ug.mL-1 PMID[572709]
NPT2 Others Unspecified IC50 > 100.0 ug.mL-1 PMID[572709]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 25.0 ug.mL-1 PMID[572709]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC254233 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.964 High Similarity NPC242764
0.964 High Similarity NPC105141
0.9381 High Similarity NPC45794
0.9316 High Similarity NPC307139
0.9244 High Similarity NPC5486
0.9115 High Similarity NPC221275
0.9 High Similarity NPC21929
0.8992 High Similarity NPC77691
0.8908 High Similarity NPC182333
0.8908 High Similarity NPC273336
0.8699 High Similarity NPC115797
0.8699 High Similarity NPC51448
0.8632 High Similarity NPC212891
0.8596 High Similarity NPC95126
0.8596 High Similarity NPC475002
0.8468 Intermediate Similarity NPC253681
0.8387 Intermediate Similarity NPC9180
0.8387 Intermediate Similarity NPC100402
0.832 Intermediate Similarity NPC169913
0.8304 Intermediate Similarity NPC19856
0.8264 Intermediate Similarity NPC202015
0.8246 Intermediate Similarity NPC94751
0.8246 Intermediate Similarity NPC142326
0.824 Intermediate Similarity NPC275576
0.824 Intermediate Similarity NPC470765
0.8211 Intermediate Similarity NPC293831
0.8211 Intermediate Similarity NPC369
0.8205 Intermediate Similarity NPC471188
0.8175 Intermediate Similarity NPC470753
0.8175 Intermediate Similarity NPC473220
0.812 Intermediate Similarity NPC133308
0.8103 Intermediate Similarity NPC475006
0.808 Intermediate Similarity NPC85511
0.8049 Intermediate Similarity NPC183339
0.8049 Intermediate Similarity NPC133389
0.8049 Intermediate Similarity NPC234337
0.8034 Intermediate Similarity NPC273837
0.8017 Intermediate Similarity NPC27252
0.8017 Intermediate Similarity NPC472979
0.8016 Intermediate Similarity NPC265413
0.8016 Intermediate Similarity NPC10154
0.8016 Intermediate Similarity NPC295664
0.8015 Intermediate Similarity NPC329913
0.8 Intermediate Similarity NPC471186
0.7965 Intermediate Similarity NPC225079
0.7965 Intermediate Similarity NPC469481
0.7965 Intermediate Similarity NPC136810
0.7965 Intermediate Similarity NPC133809
0.7965 Intermediate Similarity NPC128248
0.7953 Intermediate Similarity NPC137416
0.7937 Intermediate Similarity NPC140118
0.7937 Intermediate Similarity NPC328107
0.7937 Intermediate Similarity NPC12881
0.792 Intermediate Similarity NPC269923
0.792 Intermediate Similarity NPC167323
0.7917 Intermediate Similarity NPC153053
0.7899 Intermediate Similarity NPC270699
0.7899 Intermediate Similarity NPC82899
0.7879 Intermediate Similarity NPC126516
0.7879 Intermediate Similarity NPC203486
0.7879 Intermediate Similarity NPC48929
0.7876 Intermediate Similarity NPC221825
0.7874 Intermediate Similarity NPC474532
0.7869 Intermediate Similarity NPC470820
0.7863 Intermediate Similarity NPC472980
0.7851 Intermediate Similarity NPC473869
0.7846 Intermediate Similarity NPC147561
0.7846 Intermediate Similarity NPC131684
0.7845 Intermediate Similarity NPC243601
0.782 Intermediate Similarity NPC477893
0.782 Intermediate Similarity NPC471864
0.782 Intermediate Similarity NPC212207
0.782 Intermediate Similarity NPC477896
0.7815 Intermediate Similarity NPC305912
0.7815 Intermediate Similarity NPC1082
0.7797 Intermediate Similarity NPC149455
0.7797 Intermediate Similarity NPC64642
0.7797 Intermediate Similarity NPC472982
0.7795 Intermediate Similarity NPC51079
0.7787 Intermediate Similarity NPC9274
0.7786 Intermediate Similarity NPC249425
0.7778 Intermediate Similarity NPC473889
0.776 Intermediate Similarity NPC238861
0.776 Intermediate Similarity NPC77000
0.7759 Intermediate Similarity NPC472222
0.7759 Intermediate Similarity NPC472221
0.775 Intermediate Similarity NPC321852
0.7731 Intermediate Similarity NPC251854
0.7731 Intermediate Similarity NPC93084
0.7731 Intermediate Similarity NPC196246
0.7731 Intermediate Similarity NPC214067
0.7727 Intermediate Similarity NPC258073
0.7721 Intermediate Similarity NPC171207
0.7721 Intermediate Similarity NPC275592
0.7721 Intermediate Similarity NPC97667
0.7721 Intermediate Similarity NPC100913
0.7721 Intermediate Similarity NPC90614
0.7717 Intermediate Similarity NPC478058
0.7717 Intermediate Similarity NPC473870
0.7717 Intermediate Similarity NPC473871
0.771 Intermediate Similarity NPC471832
0.7705 Intermediate Similarity NPC474095
0.7704 Intermediate Similarity NPC262324
0.7699 Intermediate Similarity NPC226041
0.7681 Intermediate Similarity NPC477894
0.768 Intermediate Similarity NPC204784
0.7674 Intermediate Similarity NPC470816
0.7667 Intermediate Similarity NPC260818
0.7664 Intermediate Similarity NPC87448
0.7664 Intermediate Similarity NPC27377
0.7664 Intermediate Similarity NPC97947
0.7664 Intermediate Similarity NPC471862
0.7664 Intermediate Similarity NPC16912
0.7664 Intermediate Similarity NPC118080
0.7664 Intermediate Similarity NPC41481
0.7664 Intermediate Similarity NPC472576
0.7664 Intermediate Similarity NPC291599
0.7661 Intermediate Similarity NPC84129
0.7661 Intermediate Similarity NPC152812
0.7656 Intermediate Similarity NPC318067
0.7652 Intermediate Similarity NPC470278
0.7652 Intermediate Similarity NPC245927
0.7652 Intermediate Similarity NPC72915
0.7647 Intermediate Similarity NPC17417
0.7647 Intermediate Similarity NPC10251
0.7634 Intermediate Similarity NPC225103
0.763 Intermediate Similarity NPC472372
0.763 Intermediate Similarity NPC472551
0.763 Intermediate Similarity NPC309056
0.763 Intermediate Similarity NPC472545
0.763 Intermediate Similarity NPC472374
0.7623 Intermediate Similarity NPC307651
0.7619 Intermediate Similarity NPC473243
0.7619 Intermediate Similarity NPC260832
0.7619 Intermediate Similarity NPC135467
0.7615 Intermediate Similarity NPC51292
0.7612 Intermediate Similarity NPC474608
0.7603 Intermediate Similarity NPC471189
0.76 Intermediate Similarity NPC473860
0.7594 Intermediate Similarity NPC209851
0.7594 Intermediate Similarity NPC472394
0.7594 Intermediate Similarity NPC471880
0.7591 Intermediate Similarity NPC472547
0.7591 Intermediate Similarity NPC79921
0.7591 Intermediate Similarity NPC265335
0.7581 Intermediate Similarity NPC472862
0.7578 Intermediate Similarity NPC472703
0.7578 Intermediate Similarity NPC12016
0.7578 Intermediate Similarity NPC121168
0.7576 Intermediate Similarity NPC472388
0.7576 Intermediate Similarity NPC473443
0.7574 Intermediate Similarity NPC39549
0.7574 Intermediate Similarity NPC243893
0.7571 Intermediate Similarity NPC127857
0.7568 Intermediate Similarity NPC220596
0.7563 Intermediate Similarity NPC56493
0.7561 Intermediate Similarity NPC186933
0.7559 Intermediate Similarity NPC164852
0.7559 Intermediate Similarity NPC50872
0.7556 Intermediate Similarity NPC27394
0.7556 Intermediate Similarity NPC195647
0.7556 Intermediate Similarity NPC17877
0.7556 Intermediate Similarity NPC66761
0.7556 Intermediate Similarity NPC194970
0.7556 Intermediate Similarity NPC472577
0.7556 Intermediate Similarity NPC291638
0.7554 Intermediate Similarity NPC477468
0.7554 Intermediate Similarity NPC163087
0.7545 Intermediate Similarity NPC220893
0.7541 Intermediate Similarity NPC128368
0.7541 Intermediate Similarity NPC265002
0.754 Intermediate Similarity NPC42657
0.7538 Intermediate Similarity NPC475933
0.7538 Intermediate Similarity NPC476970
0.7538 Intermediate Similarity NPC470158
0.7536 Intermediate Similarity NPC224491
0.7519 Intermediate Similarity NPC470815
0.7519 Intermediate Similarity NPC475102
0.7519 Intermediate Similarity NPC472704
0.7519 Intermediate Similarity NPC469742
0.7519 Intermediate Similarity NPC472373
0.75 Intermediate Similarity NPC472569
0.75 Intermediate Similarity NPC472570
0.75 Intermediate Similarity NPC469511
0.75 Intermediate Similarity NPC249340
0.75 Intermediate Similarity NPC279463
0.75 Intermediate Similarity NPC25768
0.75 Intermediate Similarity NPC173569
0.75 Intermediate Similarity NPC95810
0.75 Intermediate Similarity NPC162935
0.75 Intermediate Similarity NPC477874
0.75 Intermediate Similarity NPC188865
0.75 Intermediate Similarity NPC70716
0.75 Intermediate Similarity NPC11685
0.75 Intermediate Similarity NPC472573
0.75 Intermediate Similarity NPC163719
0.75 Intermediate Similarity NPC125106
0.75 Intermediate Similarity NPC241951
0.75 Intermediate Similarity NPC85493
0.75 Intermediate Similarity NPC475759

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC254233 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8547 High Similarity NPD4198 Discontinued
0.8125 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7886 Intermediate Similarity NPD7741 Discontinued
0.7851 Intermediate Similarity NPD5951 Approved
0.7846 Intermediate Similarity NPD7008 Discontinued
0.776 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD5736 Approved
0.7647 Intermediate Similarity NPD2182 Approved
0.7619 Intermediate Similarity NPD5126 Approved
0.7619 Intermediate Similarity NPD5125 Phase 3
0.7561 Intermediate Similarity NPD2629 Approved
0.748 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7463 Intermediate Similarity NPD6663 Approved
0.7447 Intermediate Similarity NPD7236 Approved
0.7407 Intermediate Similarity NPD4140 Approved
0.7377 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7373 Intermediate Similarity NPD5700 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD7097 Phase 1
0.7355 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7339 Intermediate Similarity NPD6010 Discontinued
0.7333 Intermediate Similarity NPD7961 Discontinued
0.7328 Intermediate Similarity NPD1283 Approved
0.7313 Intermediate Similarity NPD7095 Approved
0.7311 Intermediate Similarity NPD164 Approved
0.731 Intermediate Similarity NPD7239 Suspended
0.7279 Intermediate Similarity NPD2979 Phase 3
0.7259 Intermediate Similarity NPD7985 Registered
0.7258 Intermediate Similarity NPD6858 Approved
0.7258 Intermediate Similarity NPD7094 Approved
0.7218 Intermediate Similarity NPD5740 Clinical (unspecified phase)
0.7218 Intermediate Similarity NPD6085 Phase 2
0.7217 Intermediate Similarity NPD6049 Phase 2
0.7217 Intermediate Similarity NPD6048 Clinical (unspecified phase)
0.7206 Intermediate Similarity NPD8032 Phase 2
0.7206 Intermediate Similarity NPD7715 Approved
0.7206 Intermediate Similarity NPD7714 Approved
0.7194 Intermediate Similarity NPD7305 Phase 1
0.7193 Intermediate Similarity NPD1088 Approved
0.7183 Intermediate Similarity NPD8166 Discontinued
0.7183 Intermediate Similarity NPD7003 Approved
0.7167 Intermediate Similarity NPD5909 Discontinued
0.7155 Intermediate Similarity NPD1989 Approved
0.7154 Intermediate Similarity NPD5235 Approved
0.7154 Intermediate Similarity NPD5236 Approved
0.7154 Intermediate Similarity NPD5240 Approved
0.7154 Intermediate Similarity NPD5239 Approved
0.7154 Intermediate Similarity NPD5237 Approved
0.7132 Intermediate Similarity NPD5585 Approved
0.7132 Intermediate Similarity NPD5691 Approved
0.7119 Intermediate Similarity NPD2066 Phase 3
0.7099 Intermediate Similarity NPD6287 Discontinued
0.7099 Intermediate Similarity NPD1281 Approved
0.7092 Intermediate Similarity NPD2346 Discontinued
0.7092 Intermediate Similarity NPD7702 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD6647 Phase 2
0.7077 Intermediate Similarity NPD4626 Approved
0.7077 Intermediate Similarity NPD3019 Approved
0.7069 Intermediate Similarity NPD688 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD4869 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD6685 Approved
0.7029 Intermediate Similarity NPD4060 Phase 1
0.7023 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD1090 Approved
0.7018 Intermediate Similarity NPD1086 Approved
0.7018 Intermediate Similarity NPD1089 Approved
0.7007 Intermediate Similarity NPD3764 Approved
0.6992 Remote Similarity NPD5327 Phase 3
0.6984 Remote Similarity NPD7635 Approved
0.697 Remote Similarity NPD4807 Approved
0.697 Remote Similarity NPD5618 Discontinued
0.697 Remote Similarity NPD4806 Approved
0.697 Remote Similarity NPD1611 Approved
0.6963 Remote Similarity NPD4624 Approved
0.696 Remote Similarity NPD4141 Clinical (unspecified phase)
0.696 Remote Similarity NPD2201 Approved
0.6953 Remote Similarity NPD3317 Approved
0.6947 Remote Similarity NPD2932 Approved
0.6947 Remote Similarity NPD3095 Discontinued
0.6947 Remote Similarity NPD5305 Approved
0.6947 Remote Similarity NPD5306 Approved
0.6947 Remote Similarity NPD1778 Approved
0.6942 Remote Similarity NPD1930 Approved
0.6942 Remote Similarity NPD1929 Approved
0.6942 Remote Similarity NPD5738 Clinical (unspecified phase)
0.6942 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6939 Remote Similarity NPD6273 Approved
0.693 Remote Similarity NPD800 Approved
0.6929 Remote Similarity NPD6353 Approved
0.6923 Remote Similarity NPD1693 Approved
0.6923 Remote Similarity NPD3091 Approved
0.6913 Remote Similarity NPD7458 Discontinued
0.6905 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6901 Remote Similarity NPD2438 Suspended
0.6901 Remote Similarity NPD2531 Phase 2
0.6894 Remote Similarity NPD3026 Approved
0.6894 Remote Similarity NPD3023 Approved
0.688 Remote Similarity NPD2067 Discontinued
0.687 Remote Similarity NPD1651 Approved
0.687 Remote Similarity NPD3024 Approved
0.687 Remote Similarity NPD3025 Approved
0.6866 Remote Similarity NPD4359 Approved
0.6857 Remote Similarity NPD5735 Approved
0.6857 Remote Similarity NPD6355 Discontinued
0.6853 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6853 Remote Similarity NPD5762 Approved
0.6853 Remote Similarity NPD5763 Approved
0.685 Remote Similarity NPD5535 Approved
0.6846 Remote Similarity NPD7644 Approved
0.6846 Remote Similarity NPD6065 Approved
0.6838 Remote Similarity NPD5122 Clinical (unspecified phase)
0.6838 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6833 Remote Similarity NPD7798 Approved
0.6833 Remote Similarity NPD1238 Approved
0.6828 Remote Similarity NPD7976 Clinical (unspecified phase)
0.6828 Remote Similarity NPD7488 Clinical (unspecified phase)
0.6828 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6818 Remote Similarity NPD4199 Phase 3
0.6818 Remote Similarity NPD7725 Approved
0.681 Remote Similarity NPD1239 Approved
0.6807 Remote Similarity NPD1565 Approved
0.6807 Remote Similarity NPD1564 Approved
0.6807 Remote Similarity NPD1566 Phase 3
0.6803 Remote Similarity NPD5765 Approved
0.68 Remote Similarity NPD5808 Clinical (unspecified phase)
0.68 Remote Similarity NPD3226 Approved
0.68 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6783 Remote Similarity NPD4477 Approved
0.6783 Remote Similarity NPD4476 Approved
0.6769 Remote Similarity NPD7325 Clinical (unspecified phase)
0.6767 Remote Similarity NPD4135 Approved
0.6767 Remote Similarity NPD4106 Approved
0.6767 Remote Similarity NPD4136 Approved
0.6767 Remote Similarity NPD3847 Discontinued
0.6765 Remote Similarity NPD2797 Approved
0.6765 Remote Similarity NPD3094 Phase 2
0.6763 Remote Similarity NPD6798 Discontinued
0.6763 Remote Similarity NPD2313 Discontinued
0.6757 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6754 Remote Similarity NPD1087 Approved
0.6753 Remote Similarity NPD7057 Phase 3
0.6753 Remote Similarity NPD7058 Phase 2
0.675 Remote Similarity NPD5926 Approved
0.6748 Remote Similarity NPD3046 Approved
0.6748 Remote Similarity NPD3047 Approved
0.6748 Remote Similarity NPD3048 Approved
0.6744 Remote Similarity NPD690 Clinical (unspecified phase)
0.6736 Remote Similarity NPD6800 Clinical (unspecified phase)
0.6726 Remote Similarity NPD5734 Clinical (unspecified phase)
0.6724 Remote Similarity NPD3672 Approved
0.6724 Remote Similarity NPD3673 Approved
0.6721 Remote Similarity NPD1932 Approved
0.672 Remote Similarity NPD2342 Discontinued
0.6718 Remote Similarity NPD7610 Discontinued
0.6716 Remote Similarity NPD3092 Approved
0.6716 Remote Similarity NPD4480 Approved
0.6714 Remote Similarity NPD6233 Phase 2
0.6713 Remote Similarity NPD2799 Discontinued
0.6712 Remote Similarity NPD4628 Phase 3
0.6712 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6712 Remote Similarity NPD4110 Phase 3
0.6694 Remote Similarity NPD5048 Discontinued
0.6692 Remote Similarity NPD7157 Approved
0.6692 Remote Similarity NPD4059 Approved
0.6691 Remote Similarity NPD5454 Clinical (unspecified phase)
0.6691 Remote Similarity NPD6696 Suspended
0.6691 Remote Similarity NPD5667 Approved
0.669 Remote Similarity NPD4579 Clinical (unspecified phase)
0.669 Remote Similarity NPD4097 Suspended
0.6667 Remote Similarity NPD1608 Approved
0.6667 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6032 Approved
0.6667 Remote Similarity NPD1894 Discontinued
0.6667 Remote Similarity NPD6099 Approved
0.6667 Remote Similarity NPD7250 Approved
0.6667 Remote Similarity NPD6637 Approved
0.6667 Remote Similarity NPD2329 Discontinued
0.6667 Remote Similarity NPD4479 Discontinued
0.6667 Remote Similarity NPD2106 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7249 Approved
0.6667 Remote Similarity NPD6100 Approved
0.6644 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6643 Remote Similarity NPD3268 Approved
0.6643 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6643 Remote Similarity NPD41 Approved
0.6643 Remote Similarity NPD5886 Approved
0.6642 Remote Similarity NPD3496 Discontinued
0.6642 Remote Similarity NPD3898 Approved
0.6642 Remote Similarity NPD6362 Approved
0.6642 Remote Similarity NPD3895 Approved
0.6642 Remote Similarity NPD3896 Approved
0.6642 Remote Similarity NPD3897 Approved
0.6641 Remote Similarity NPD6912 Phase 3
0.6641 Remote Similarity NPD4230 Clinical (unspecified phase)
0.6641 Remote Similarity NPD7340 Approved
0.6638 Remote Similarity NPD5346 Phase 2
0.6638 Remote Similarity NPD5347 Phase 2
0.6621 Remote Similarity NPD6002 Phase 3
0.6621 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6621 Remote Similarity NPD6005 Phase 3
0.6621 Remote Similarity NPD6003 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data